Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shiva, Vonk"'
Autor:
Marte C Liefaard, Anna van der Voort, Joyce Sanders, Shiva Vonk, Hugo M Horlings, Sabine Siesling, Linda de Munck, Elise van Leeuwen-Stok, Miranda Kleijn, Lorenza Mittempergher, Midas M Kuilman, Esther H Lips, Gabe S Sonke
Publikováno v:
Cancer Research. 82:PD15-07
Background: The addition of pertuzumab to neoadjuvant trastuzumab-containing chemotherapy significantly improves pathological complete response (pCR) rates in patients with HER2-positive breast cancer. However, effects on long-term survival outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a214f2d0dc5b265a883d77f2e5ca7130
https://doi.org/10.1158/1538-7445.sabcs21-pd15-07
https://doi.org/10.1158/1538-7445.sabcs21-pd15-07
Autor:
Mathilde M, Almekinders, Tycho, Bismeijer, Tapsi, Kumar, Fei, Yang, Bram, Thijssen, Rianne, van der Linden, Charlotte, van Rooijen, Shiva, Vonk, Baohua, Sun, Edwin R, Parra Cuentas, Ignacio I, Wistuba, Savitri, Krishnamurthy, Lindy L, Visser, Iris M, Seignette, Ingrid, Hofland, Joyce, Sanders, Annegien, Broeks, Jason K, Love, Brian, Menegaz, Lodewyk, Wessels, Alastair M, Thompson, Karin E, de Visser, Erik, Hooijberg, Esther, Lips, Andrew, Futreal, Jelle, Wesseling
Publikováno v:
British journal of cancer. 127(7)
Ductal carcinoma in situ (DCIS) is treated to prevent subsequent ipsilateral invasive breast cancer (iIBC). However, many DCIS lesions will never become invasive. To prevent overtreatment, we need to distinguish harmless from potentially hazardous DC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee2c8544327a38ccc8865101644c501f
https://pubmed.ncbi.nlm.nih.gov/35768550
https://pubmed.ncbi.nlm.nih.gov/35768550